发明名称 |
Recombinant Gallid herpesvirus 3 (MDV serotype 2) vectors expressing antigens of avian pathogens and uses thereof |
摘要 |
The present invention provides recombinant Gallid herpesvirus 3 (MDV-2) vectors that contain and express antigens of avian pathogens, recombinant Gallid herpesvirus 3 (MDV-2) vectors that contain a mutated gC gene, compositions comprising the recombinant Gallid herpesvirus 3 (MDV-2) vectors, polyvalent vaccines comprising the recombinant Gallid herpesvirus 3 (MDV-2) vectors and one or more wild type viruses or recombinant vectors. The present invention further provides methods of vaccination against a variety of avian pathogens and method of producing the recombinant Gallid herpesvirus 3 (MDV-2) vectors. |
申请公布号 |
US9101598(B2) |
申请公布日期 |
2015.08.11 |
申请号 |
US201213689572 |
申请日期 |
2012.11.29 |
申请人 |
MERIAL, INC. |
发明人 |
Bublot Michel;Mebatsion Teshome;Pritchard Joyce;Linz Perry |
分类号 |
A61K39/245;A61K39/17;A61K39/295;A61K39/12;C12N15/869;C12N15/38;C12N15/45;A61K39/00 |
主分类号 |
A61K39/245 |
代理机构 |
Merial, Inc. |
代理人 |
Jarecki-Black Judy;Chen Ruoying;Merial, Inc. |
主权项 |
1. A vaccine composition comprising:
1) a recombinant Gallid herpesvirus 3 (MDV-2) strain SB-1 vector, wherein said vector comprises a heterologous polynucleotide coding for and expressing in vivo, a Newcastle Disease Virus (NDV) Fusion protein (NDV-F), and 2) a pharmaceutically or veterinarily acceptable carrier, excipient, vehicle or adjuvant; wherein the NDV-F protein has at least 99% sequence identity to a polypeptide having the sequence as set forth in SEQ ID NO:2 or wherein the NDV-F protein comprises SEQ ID NO:9. |
地址 |
Duluth GA US |